Charlotte-based Elevation Church is set to launch its own Elevation College program in the fall of 2026, thanks to a partnership with Southeastern University. Ben Sasse reveals pancreatic cancer ...

In what may be the ultimate Wall Street meets Main Street story, Goldman Sachs has agreed to buy Wheaton-based Innovator Capital Management, an 8-year-old ETF investment firm, for $2 billion. Founded ...

MCLEAN, Va.--(BUSINESS WIRE)--Vest, the innovative financial firm that created the first Buffer Fund and pioneered defined outcome investing, today announced Synthetic Borrow™, an advisor-ready ...

New digital platform seeks to offer fixed-term, institutional-grade financing to advisors and their clients. Vest, the innovative financial firm that created the first Buffer Fund and pioneered ...

On his “States of Elevation” project, Kilian Jornet intends to summit the 60-plus so-called 14ers in the contiguous United States, connecting each by bike or foot. On his “States of Elevation” project ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

NEW YORK, August 4 (Reuters) - Investors are piling into financial products that offer them the chance to forgo some potential gains in exchange for protection against a market selloff, with the ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.

Elevation Point, a minority investor in independent and breakaway advisors launched last year by former Sanctuary Wealth CEO Jim Dickson, has made another move to strengthen its senior leadership team ...

Russian armed forces are creating a “security buffer zone” along the border between Russia and Ukraine, President Vladimir Putin said Thursday. “I have already said that a decision was made to create ...

Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for weight loss or diabetes management doesn ’t raise the risk for adverse psychiatric events and improves quality of life (QOL) in ...